Page last updated: 2024-11-07

samarium oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID159425
MeSH IDM0332093

Synonyms (23)

Synonym
samarium (iii) oxide
samarium(iii) oxide
samarium trioxide
samarium oxide
samarium sesquioxide
einecs 235-043-6
samarium(3+) oxide
samaria
samarium oxide (sm2o3)
disamarium trioxide
91n8739x2n ,
12060-58-1
ec 235-043-6
unii-91n8739x2n
12651-06-8
samarium oxydatum
samarium oxide [mi]
FKTOIHSPIPYAPE-UHFFFAOYSA-N
samarium(3+) oxide (2/3)
DTXSID30925575
Q421401
oxygen(2-);samarium(3+)
oxo(oxosamariooxy)samarium

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In terms of the bioavailability of caffeine, the most important factor seemed to be the residence time in the ascending and transverse colon."( Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet constant-release drug delivery system.
Ariniemi, K; Hietanen, H; Kanerva, H; Kekki, T; Lindevall, K; Lipponen, M; Marvola, J; Marvola, M; Mykkänen, S; Slot, L, 2004
)
0.32
"5% plasma bioavailability across four formulations tested."( Oral delivery of antisense oligonucleotides in man.
Geary, RS; Hardee, GE; Tillman, LG, 2008
)
0.35
" While comparing the results to those previously obtained from the bioavailability studies it could be concluded that it is possible to develop colon specific drug products that begin releasing the drug in the ileo-caecal junction or at the beginning of the ascending colon and spread the drug dose to a larger surface area by using enteric coats and hydrophilic polymers."( Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
Ahonen, A; Kanerva, H; Lindevall, K; Marvola, J; Marvola, M; Marvola, T, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" In this study, a variety of oral solid dosage formulations were evaluated and it was determined that pulsing the delivery of sodium caprate (C10), a well-known permeation enhancer, in a novel manner may provide optimal ASO plasma bioavailability."( Oral delivery of antisense oligonucleotides in man.
Geary, RS; Hardee, GE; Tillman, LG, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's7 (35.00)29.6817
2010's8 (40.00)24.3611
2020's4 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.93 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index54.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (15.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (85.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]